Study Details

General Information

Pfizer OA-Hip/Knee Sub-Study A4091064

A Phase 3 Randomized, Multicenter Study of the Long-Term Observational Study of Subjects from Tanezumab Studies Who Undergo A Total Knee, or Shoulder Replacement.

ProtocolA4091064
IdentifierSite No:1118
UID8c458059-fbff-4f61-a2ba-4841079f9f87
StatusPI Declined
Phase3
CategoryOsteoarthritis / Adult
Launch Year2015
NCT Number-
Created2015-04-20 15:48
Last Updated2015-04-20 15:48

Description

No description provided.

Comment

No comment.

Target Dates

NameDateRequired
Enrollment ClosedNo
Enrollment OpenNo
First Patient First VisitNo
Site Initiation Mtg.No
PI Meeting StartNo
PI Meeting EndNo
PI Meeting ArrivalNo
PI Meeting DepartureNo
Closeout DateNo
Final PatientVisitNo
PreStudy Selection VisitNo
Target Date 12No
Target Date 13No
Target Date 14No

Leadership

RoleStaffLoginRequired
PrincipalMartinez, GilbertGJMartinezNo
Recruiter-No
CoordinatorValenzuela, LouisitoLValenzuelaNo
RegulatoryAguirre, SandraSAguirreNo

Custom Fields

No custom fields.

Sponsor & Organization

SponsorPfizer
DivisionPfizer
TeamPfizer
Managing SiteCatalina Research Institute, LLC
Organization

Contacts

IRB Ref
CROInventiv Health Clinical, LLC
CRO Ref
Correspondence0

Opportunity

Probability0
Comment
Status ColorGray
Currency-
Mayra Sibley

2 Hours

Hi there, I'm Jesse and you?
You

3 minutes

My name is Anne Clarc.
Mayra Sibley

40 seconds

Nice to meet you Anne.
How can i help you?